Last reviewed · How we verify

CA125 guided strategy — Competitive Intelligence Brief

CA125 guided strategy (CA125 guided strategy) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

marketed Oncology Small molecule Live · refreshed every 30 min

Target snapshot

CA125 guided strategy (CA125 guided strategy) — Fundación para la Investigación del Hospital Clínico de Valencia. CA125 guided strategy uses serial measurement of the tumor marker CA125 to inform treatment decisions and monitoring in ovarian cancer patients.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
CA125 guided strategy TARGET CA125 guided strategy Fundación para la Investigación del Hospital Clínico de Valencia marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CA125 guided strategy — Competitive Intelligence Brief. https://druglandscape.com/ci/ca125-guided-strategy. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: